Fondazione Piemontese per la Ricerca sul Cancro Onlus
- World rank, all time
- #31,547 of 42,892
- Rank in Italy
- #844 of 969
- Research works
- 120 ▼ 71% vs 2013–17
- Citations
- 4.7k 39.3 per fractional work
- Top-10% rate
- 9.7% record average 16.5%
- Open access
- 34% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 6.2×. Every wedge is a field page.
Which keywords describe research at Fondazione Piemontese per la Ricerca sul Cancro Onlus?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Radiotherapy, Immunotherapy, Molecular Subtypes, Molecular Characterization and Survival Analysis.
- Chemotherapy-Induced Peripheral Neuropathy
- Neurotoxicity
- Liver Cancer
- Genetic Testing
- Receptor tyrosine kinases
- Cancer Risk
- Cholangiocarcinoma
- Genetic Mutations
- Metastatic
- Screening
- Metastatic Breast Cancer
- Surgical Management
- Clinical Trials
- Treatment
- Neoadjuvant Therapy
- Precision Medicine
- Molecular Characterization
- Quality of Life
- Radiotherapy
- Clinical Practice Guidelines
- Chemotherapy
- Prognostic Factors
- Immunotherapy
- Molecular Subtypes
- Survival Analysis
- Breast Cancer
- Targeted Therapy
- Cetuximab
- Survival
- Adjuvant Chemotherapy
- Hepatocellular Carcinoma
- Gene Expression
- Fluorouracil
- KRAS Mutations
- Mortality
- Prostate Cancer
- Tumor Microenvironment
- Genomic Profiling
- Radiofrequency Ablation
- Trastuzumab
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy15▲ 18×19 topics
- Clinical Practice Guidelines10▲ 16×9 topics
- Prognostic Factors8▲ 14×13 topics
- Radiotherapy8▲ 17×12 topics
- Immunotherapy7▲ 8.4×14 topics
- Quality of Life6▲ 3.9×11 topics
- Molecular Subtypes6▲ 58×2 topics
- Molecular Characterization6▲ 26×5 topics
- Survival Analysis6▲ 18×6 topics
- Precision Medicine6▲ 15×5 topics
- Breast Cancer5▲ 16×8 topics
- Neoadjuvant Therapy5▲ 20×5 topics
- Targeted Therapy5▲ 20×5 topics
- Treatment5▲ 3.3×10 topics
- Cetuximab5▲ 49×2 topics
- Clinical Trials5▲ 6.6×7 topics
- Survival5▲ 30×3 topics
- Surgical Management4▲ 7.6×5 topics
- Adjuvant Chemotherapy4▲ 46×2 topics
- Metastatic Breast Cancer4▲ 50×2 topics
- Hepatocellular Carcinoma4▲ 15×2 topics
- Screening4▲ 33×2 topics
- Gene Expression4▲ 5.0×6 topics
- Metastatic4▲ 48×2 topics
- Fluorouracil4▲ 88×1 topic
- Genetic Mutations4▲ 5.7×10 topics
- KRAS Mutations4▲ 88×1 topic
- Cholangiocarcinoma4▲ 37×2 topics
- Mortality4▲ 5.9×4 topics
- Cancer Risk3▲ 11×4 topics
- Prostate Cancer3▲ 19×3 topics
- Receptor tyrosine kinases3▲ 62×2 topics
- Tumor Microenvironment3▲ 7.7×7 topics
- Genetic Testing3▲ 17×3 topics
- Genomic Profiling3▲ 27×2 topics
- Liver Cancer3▲ 51×1 topic
- Radiofrequency Ablation3▲ 24×1 topic
- Neurotoxicity3▲ 14×2 topics
- Trastuzumab3▲ 60×2 topics
- Chemotherapy-Induced Peripheral Neuropathy3▲ 49×1 topic
Which research topics does Fondazione Piemontese per la Ricerca sul Cancro Onlus publish most on?
By volume in 2022–2025: Melanoma and MAPK Pathways, Synthesis and biological activity, Thermochemical Biomass Conversion Processes and Click Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Melanoma and MAPK Pathways Molecular Biology 0 works
- 2 Synthesis and biological activity Organic Chemistry 0 works
- 3 Thermochemical Biomass Conversion Processes Biomedical Engineering 0 works
- 4 Click Chemistry and Applications Organic Chemistry 0 works
- 5 Photovoltaic Systems and Sustainability Environmental Engineering 0 works
- 6 Chemical Looping and Thermochemical Processes Biomedical Engineering 0 works
- 7 Colorectal Cancer Treatments and Studies Oncology 0 works
- 8 Cancer Treatment and Pharmacology Oncology 0 works
- 9 Cancer Genomics and Diagnostics Cancer Research 0 works
- 10 Immune cells in cancer Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fondazione Piemontese per la Ricerca sul Cancro Onlus's research output changed?
Output in 2018–2022 was 71% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Candiolo
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.